Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-03-30

Clinical Trial Update: Effect of Preemptive Etoricoxib and Dexamethasone on Wound Healing and Clinical Parameters After Third Molar Surgery [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating preemptive etoricoxib and dexamethasone on wound healing and postoperative pain after third molar extraction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)
  • Etoricoxib (etoricoxib)

Snippet

Sponsor: University of Belgrade | Conditions: Surgical Wound, Post Operative Pain | Phase 4 | Status: COMPLETED